home / stock / halo / halo quote
Last: | $38.26 |
---|---|
Change Percent: | 1.19% |
Open: | $37.73 |
Close: | $37.81 |
High: | $38.645 |
Low: | $37.73 |
Volume: | 103,386 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$38.26 | $37.73 | $37.81 | $38.645 | $37.73 | 103,386 | 04-19-2024 |
$37.81 | $37.95 | $37.81 | $38.41 | $37.73 | 792,436 | 04-18-2024 |
$38.02 | $38.69 | $38.02 | $38.78 | $37.9817 | 733,857 | 04-17-2024 |
$38.38 | $38.35 | $38.38 | $38.81 | $38.085 | 642,294 | 04-16-2024 |
$38.72 | $38.89 | $38.72 | $39.27 | $38.48 | 843,658 | 04-15-2024 |
$38.61 | $39 | $38.61 | $39.28 | $38.53 | 780,317 | 04-12-2024 |
$39.32 | $39.49 | $39.32 | $39.79 | $39.155 | 733,624 | 04-11-2024 |
$39.28 | $39.25 | $39.28 | $39.84 | $38.9 | 1,882,282 | 04-10-2024 |
$40.13 | $40.07 | $40.13 | $40.71 | $39.515 | 719,105 | 04-09-2024 |
$39.91 | $41.09 | $39.91 | $41.355 | $39.85 | 1,163,918 | 04-08-2024 |
$41.07 | $39.8 | $41.07 | $41.5 | $39.8 | 1,327,614 | 04-05-2024 |
$39.73 | $40.4 | $39.73 | $40.63 | $39.44 | 1,040,319 | 04-04-2024 |
$40.23 | $40.3 | $40.23 | $40.67 | $39.99 | 689,359 | 04-03-2024 |
$40.43 | $40.81 | $40.43 | $40.94 | $39.7 | 943,225 | 04-02-2024 |
$41.32 | $40.68 | $41.32 | $41.6 | $40.375 | 813,128 | 04-01-2024 |
$40.68 | $40.82 | $40.68 | $40.99 | $40.44 | 707,395 | 03-29-2024 |
$40.68 | $40.82 | $40.68 | $40.99 | $40.44 | 707,395 | 03-28-2024 |
$40.73 | $40.51 | $40.73 | $40.94 | $40.31 | 601,140 | 03-27-2024 |
$40.08 | $40.57 | $40.08 | $40.58 | $39.94 | 625,814 | 03-26-2024 |
$40.42 | $40 | $40.42 | $40.61 | $39.9 | 672,983 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
2024-04-16 12:15:03 ET JMP Securities analyst issues BUY recommendation for HALO on April 16, 2024 10:01AM ET. The previous analyst recommendation was Buy. HALO was trading at $38.59 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Biophytis posted a FY23 lo...
2024-04-02 04:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...